期刊文献+

唑来膦酸对肺癌95D细胞周期阻滞和诱导凋亡的作用机制 被引量:4

Zoledronic acid blocks cell cycle and induces apoptosis in lung cancer cell line 95D cells and their mechanisms of action
原文传递
导出
摘要 目的研究唑来膦酸对肺癌95D细胞的细胞周期阻滞及诱导凋亡作用。方法采用二苯基溴化四氮唑蓝法检测唑来膦酸对肺癌95D细胞增殖的影响;采用流式细胞仪检测唑来膦酸作用后肺癌95D细胞的细胞周期和凋亡的变化,并在光镜和电镜下观察细胞凋亡的形态变化;采用Westernblot和逆转录聚合酶链反应检测唑来膦酸对肺癌95D细胞凋亡相关基因ERK1/ERK2、bcl-2、bax和survivin表达水平的影响。结果唑来膦酸对肺癌95D细胞的增殖抑制作厢呈时间和浓度依赖性,94.0%μmol/L唑来膦酸作用6d时,抑制率达89.8%。随着唑来膦酸作用时间的延长,G1期细胞数量增多,G2期和S期细胞减少,凋亡细胞的数量逐渐增多。光镜和电镜均观察到细胞出现了相应的凋亡形态学变化。细胞凋亡相关基因ERK、bcl-2和survivin的表达水平下降,bax的表达水平增高。结论唑来膦酸对肺癌95D细胞的细胞周期有阻滞作用,并能诱导其凋亡。 Objective To study the effect of zoledronic acid on cell cycle blocking and induction of apoptosis in lung cancer cell line 95D cells, and their mechanisms of action. Methods The effect of zoledronie acid (ZOL) on proliferation of lung cancer cell line 95D cells was observed by MTF assay. Cell cycle and apoptosis of the lung cancer cells was examined by flow cytometry. The apoptosis in the cancer cells was also examined by light and transmission electron microscopy. The expressions of ERK, Bcl-2, Bax and survivin were measured by Western blot and RT-PCR. Results ZOL showed inhibitory effect on the proliferation of lung cancer cells in vitro, in a time-dependant and a dose-dependant manner. With time extending after ZOL treatment, the number of apoptosis cells was increased. The expression of ERK, Bcl-2 and survivin was down-regulated and that of Bax up-regulated. Conclusion Zoledronic acid can block the cell cycle and induce apoptosis in lung cancer cells in vitro.
出处 《中华肿瘤杂志》 CAS CSCD 北大核心 2009年第6期418-422,共5页 Chinese Journal of Oncology
关键词 唑来膦酸 肺肿瘤 细胞周期 凋亡 Zoledronic acid Lung neoplasms Cell cycle Apoptosis
  • 相关文献

参考文献14

  • 1Evdokiou A, Labrinidis A, Bouralexis S. Induction of cell death of human osteogenic sarcoma cells by zoledronic acid resembles anoikis. Bone, 2003, 33:216-228.
  • 2Neville-Webbe H, Coleman RE. The use of zoledronic acid in the management of metastatic bone disease and hypercalcaernia. Palliat Med, 2003, 17:539-553.
  • 3童向东,刘宏旭,赵惠儒,许世广,李玉,韩立波,张林.Smad4蛋白与蛋白激酶在非小细胞肺癌信号传导通路中的作用[J].中华肿瘤杂志,2006,28(10):741-745. 被引量:18
  • 4黄陈,裘正军,曹俊,黄克俭,张放,江弢,朱麟,刘俊.AG490抑制人胰腺癌细胞侵袭转移的体外研究[J].中华肿瘤杂志,2006,28(12):890-893. 被引量:6
  • 5Miller PD, Brown JP, Siris ES, et al. A randomized, double-blind comparison of risedronate and etidronate in the treatment of Paget's disease of bone. Paget's Risedronate/Etidronate Study Group. Am J Med, 1999, 106:513-520.
  • 6Li X, IAu L, Tupper JC, et al. Inhibition of protein geranylgernaylation and RhoA/RhoA kinase pathway induces apoptosis in human endothelial cells. J Biol Chem, 2002, 277:15309-15316.
  • 7Pruitt K, Der CJ. Ras and Rho regulation of the cell cycle and oncogenesis. Cancer Lett, 2001, 171:1-10.
  • 8Gesi M, Pellegrini A, Soldani P, et al. Ultrastructural and biochemical evidence of apoptosis induced by a novel inhibitor of protein geranylgeranylation in human MIA PaCa-2 pancreatic cancer cells. Ultrastruct Pathol, 1998, 22:253-261.
  • 9Gordon S, Helfrich MH, Sati HI, et al. Pamidronate causes apoptosis of plasma cells in vivo in patients with multiple myeloma. Br J Haematol, 2002, 119:475-483.
  • 10Jagdev SP, Croucher PI, Coleman RE. Zoledronate induces apoptosis of breast cancer cells in vitro-evidence for additive and synergistic effects with taxol and tamoxifen. Proc Am Soc Clin Oncol, 2000, 19:664.

二级参考文献16

  • 1裘正军,刘辰,胡宏慧,曹俊.STAT3和Cyclin D1在胰腺癌中的表达及其临床意义[J].胰腺病学,2005,5(1):24-27. 被引量:12
  • 2洪富源,孙芳,刘军,姚建,黄一新,唐知还.细胞内活性氧在甲基乙二醛促人腹膜间皮细胞分泌血管内皮生长因子中的作用[J].肾脏病与透析肾移植杂志,2005,14(4):329-332. 被引量:6
  • 3Aristidis M,Serhiy S,Carl-Henrik H.Smad regulation in TGF-β signal transduction.J Cell Science,2001,114:4359-4369.
  • 4Johnson GL,Lapadat R.Mitogen activated protein kinase pathways mediated by ERK,JNK and p38 protein kinases.Science,2002,298:1911-1912.
  • 5Nancy D,Andrei VB,Carlos LA.Autocrine transforming growth factor-β signaling mediates smad-independent motility in human cancer cells.J Biol Chem,2003,278:3275-3285.
  • 6Maliekal TT,Antony ML,Nair A,et al.Loss of expression,and mutation of Smad 2 and Smad4 in human cervical cancer.Oncogene,2003,22:4889-4897.
  • 7Campbell SL,Khosravi FR,Rossman KL,et al.Increasing complexity of Ras signaling.Oncogene,1998,17:1395-1413.
  • 8Greenberg AK,Basu S,Hu J,et al.Selective p38 activation in human non-small cell lung cancer.Am J Respir Cell Mol Biol,2002,26:558-564.
  • 9Xiao L,Lang W.A dominant role for the c-Jun NH2-terminal kinase in oncogenic ras-induced morphologic transformation of human lung carcinoma cells.Cancer Res,2000,60:400-408.
  • 10Fu Y,O' Connor LM,Shepherd T G,et al.The p38 MAPK inhibitor,PD169316,inhibits transforming growth factor betainduced Smad signaling in human ovarian cancer cells.Biochem Biophys Res Commun,2003,310:391-397.

共引文献22

同被引文献43

  • 1赵建平,王媛媛,阎玉虎.吉西他滨对人非小细胞肺癌A549细胞增殖与凋亡的影响[J].肿瘤防治研究,2006,33(2):100-102. 被引量:4
  • 2Yuasa T, Kimura S, Ashihara E, et al. Zoledronic acid - a multiplicity of anti-cancer action. Curr Med Chem, 2007, 14: 2126-2135.
  • 3Winter MC, Holen I, Coleman RE. Exploring the anti-tumour activity of bisphosphonates in early breast cancer. Cancer Treat Rev ,2008,34:453-475.
  • 4Gnant M, Mlineritsch B, Sehippinger W, et al. Endocrine Therapy plus Zoledronie Acid in Premenopausal Breast Cancer. N Engl J Med,2009, 360:679-691.
  • 5Facchini G, Caraglia M, Morabito A, et al. Metronomic administration of zoledronic acid and taxotete combination in eastration resistant prostate cancer patients: Phase I ZANTE trial. Cancer Biol Ther,201 O, 10:543-548.
  • 6Aft R, Naughton M, Trinkaus K, et al. Effect of zoledronic acid on disseminated tumour cells in women with locally advanced breast cancer : an open label, randomised, phase 2 trial. Lancet 0ncol,2010,11:421-428.
  • 7Ottewell PD, Deux B, Monkksnen H, et al. Differential effect of doxorubicin and zoledronic acid on intraosseous versus extraosseous breast tumor growth in vivo. Clin Cancer Res,2008,14: 4658- 4666.
  • 8Neville-Webbe HL, Coleman RE, Holen I. Combined effects of the bisphosphonate, zoledronic acid and the aromatase inhibitor letrozole on breast cancer cells in vitro: evidence of synergistic interaction. Br J Cancer,2010,102 : 1010-1017.
  • 9Rachner TD, Singh SK, Schoppet M, et al. Zoledronic acid induces apoptosis and changes the TRAIL/OPG ratio in breast cancer cells. Cancer Lett,2010,287 : 109-116.
  • 10Karabulut B, Karaca B, Varol U, et al. Enhancing cytotoxic and apoptotic effect in OVCAR-3 and MDAH-2774 cells with all-trans retinoic acid and zoledronic acid: a paradigm of synergistic molecular targeting treatment for ovarian cancer. J Exp Clin Cancer Res ,2010,29 : 102.

引证文献4

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部